Synthesis and cytotoxic evaluation of novel quinozalinone derivatives with substituted benzimidazole in position 3

Elham Taherian , Ghadamali Khodarahmi , Marzieh Rahmani Khajouei, Farshid Hassanzadeh, Nasim Dana

Abstract


Quinazolinone and benzimidazole are both fused heterocyclic compounds which have shown valuable biological properties including cytotoxic, antibacterial, and antifungal activities. In this study, a series of novel quinazolinone derivatives substituted with benzimidazole were synthesized in two parts.  In the first part 2 - phenyl - 1H - benzimidazol - 6 - amine (4) was synthesized from the reaction of 4-nitro-o-phenylenediamine and benzoic acid. In the second part, new 3-(2-phenyl-1H benzoimidazol-5-yl)-3H-quinazolin-4-one derivatives (8a-8f) were also prepared. Finally compound 4 was reacted with the different benzoxazinone derivatives (8a-8f) to give the target compounds. The structures of the synthesized compounds were confirmed by IR and 1HNMR. Cytotoxic activities of the final compounds were assessed at 100, 200, 300, 400, and 500 μM against MCF-7 and HeLa cell lines using the MTT colorimetric assay. Almost all compounds exhibited good cytotoxic activity against both cell lines. Compound 9d demonstrated the highest cytotoxic activity against MCF7 and Hela cell lines with IC50 70 μM and 50 μM, respectively.


Keywords


Cytotoxicity; Benzimidazole; MTT assay; Quinazolinone.

Full Text:

PDF

References


Paul K, Sharma A, Luxami V. Synthesis and in vitro antitumor evaluation of primary amine substituted quinazoline linked benzimidazole. Bioorganic Med Chem Lett. 2014;24(2):624-629.

Kemnitzer W, Kuemmerle J, Jiang S, Zhang HZ, Sirisoma N, Kasibhatla S, et al. Discovery of 1-benzoyl-3-cyanopyrrolo[1,2-a]quinolines as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. Part 1: Structure-activity relationships of the 1- and 3-positions. Bioorg Med Chem Lett. 2008;18(23):6259-6264.

Alagarsamy V, Chitra K, Saravanan G, Solomon VR, Sulthana MT, Narendhar B. An overview of quinazolines: Pharmacological significance and recent developments. Eur J Med Chem. 2018;151:628-685.

Hassanzadeh F, Jafari E, Hakimelahi GH, Rahmani Khajouei M, Jalali M, Khodarahmi GA. Antibacterial, antifungal and cytotoxic evaluation of some new quinazolinone derivatives. Res Pharm Sci. 2012;7(2):87-94.

Takeuchi Y, Azuma K, Takakura K, Abe H, Kim HS, Wataya Y, et al. Asymmetric synthesis of (+)-febrifugine and (+)-isofebrifugine using yeast reduction. Tetrahedron. 2001;57(7):1213-1218.

Chen Z, Hu G, Li D, Chen J, Li Y, Zhou H, et al. Synthesis and vasodilator effects of rutaecarpine analogues which might be involved transient receptor potential vanilloid subfamily, member 1 (TRPV1). Bioorg Med Chem. 2009;17(6):2351-2359.

Chavan SP, Sivappa R. A short and efficient general synthesis of luotonin A, B and E. Tetrahedron. 2004;60(44):9931-9935.

Maitraie D, Venkat Reddy G, Rama Rao VVVNS, Ravi Kanth S, Shanthan Rao P, Narsaiah B. A simple and facile method for the synthesis of novel 5/7 trifluoromethyl-substituted 4(3H)-quinazolone regioisomers. J Fluorine Chem. 2002;118(1-2):73-79.

Jatav V, Mishra P, Kashaw S, Stables JP. Synthesis and CNS depressant activity of some novel 3-[5-substituted 1,3,4-thiadiazole-2-yl]-2-styryl quinazoline-4(3H)-ones. Eur J Med Chem. 2008;43(1):135-141.

Shcherbakova I, Balandrin MF, Fox J, Ghatak A, Heaton WL, Conklin RL. 3H-Quinazolin-4-ones as a new calcilytic template for the potential treatment of osteoporosis. Bioorg Med Chem Lett. 2005;15(6):1557-1560.

Jafari E, Khajouei MR, Hassanzadeh F, Hakimelahi GH, Khodarahmi GA. Quinazolinone and quinazoline derivatives: recent structures with potent antimicrobial and cytotoxic activities. Res Pharm Sci. 2016;11(1):1-14.

Al-Rashood ST, Aboldahab IA, Nagi MN, Abouzeid LA, Abdel-Aziz AA, Abdel-Hamide SG, et al. Synthesis, dihydrofolate reductase inhibition, antitumor testing, and molecular modeling study of some new 4(3H)-quinazolinone analogs. Bioorg Med Chem. 2006;14(24):8608-8621.

Taliani S, Pugliesi I, Barresi E, Salerno S, Marchand C, Agama K, et al. Phenylpyrazolo[1,5-a]quinazolin-5(4H)-one: a suitable scaffold for the development of noncamptothecin topoisomerase I (Top1) inhibitors. J Med Chem. 2013;56(18):7458-7462.

Matthews TP, Jones AM, Collins I. Structure-based design, discovery and development of checkpoint kinase inhibitors as potential anticancer therapies. Expert Opin Drug Discov. 2013;8(6):621-640.

Cruz-Lopez O, Conejo-Garcia A, Nunez MC, Kimatrai M, Garcia-Rubino ME, Morales F, et al. Novel substituted quinazolines for potent EGFR tyrosine kinase inhibitors. Curr Med Chem. 2011;18(7):943-963.

Chebolu R, Kommi DN, Kumar D, Bollineni N, Chakraborti AK. Hydrogen-bond-driven electrophilic activation for selectivity control: scope and limitations of fluorous alcohol-promoted selective formation of 1,2-disubstituted benzimidazoles and mechanistic insight for rationale of selectivity. J Org Chem. 2012;77(22):10158-10167.

Zohdi HF, RatebN M, Khlosy TA. Synthesis, reaction and antimicrobial activity of some pyridinethione derivatives containing benzimidazole nucleus. Int J Adv Res. 2014;2(4):861-872.

Dawood K, Elwan N, Farahat A, Abdel-Wahab B. 1 H -Benzimidazole-2-acetonitriles as synthon in fused benzimidazole synthesis. J. Heterocycl Chem. 2010;47(2):243-289.

Mavrova A, Vuchev D, Anichina K, Vassilev N. Synthesis, antitrichinnellosis and antiprotozoal activity of some novel thieno[2,3-d]pyrimidin-4(3H)-ones containing benzimidazole ring. Eur J Med Chem. 2010;45(12):5856-5861.

Siddiqui N, Alam M, Sahu M, Shahar Yar M, Alam O, Siddiqui MJ. Antidepressant, analgesic activity and SAR studies of substituted benzimidazoles. AJPR. 2016;6(3):170-174.

Shrivastava N, Naim MJ, Alam MJ, Nawaz F, Ahmed S, Alam O. Benzimidazole scaffold as anticancer agent: synthetic approaches and structure-activity relationship. Arch Pharm (Weinheim). 2017;350(6). DOI: 10.1002/ardp.201700040.

Shi L, Wu TT, Wang Z, Xue JY, Xu YG. Discovery of N -(2-phenyl-1H-benzo[d]imidazol-5-yl) quinolin-4-amine derivatives as novel VEGFR-2 kinase inhibitors. Eur J Med Chem. 2014;84:698-707.

Hosseinzadeh L, Aliabadi A, Rahnama M, Sadeghi HMM, Khajouei MR. Synthesis and cytotoxic evaluation of some new 3-(2-(2-phenylthiazol-4-yl) ethyl)-quinazolin-4(3H) one derivatives with potential anticancer effects. Res Pharm Sci. 2017;12(4):290-298.

Poorirani S, Sadeghian-Rizi S, Khodarahmi G, Khajouei MR, Hassanzadeh F. Synthesis and cytotoxic evaluation of novel quinazolinone derivatives as potential anticancer agents. Res Pharm Sci. 2018;13(5):450-459.

Khodarahmi GA, Hassanzadeh F, Jafarian A, Chiniforoosh AH, Hajseyedabutorabi AM. Cytotoxic effects of some 1-[(benzofuran-2-yl)-phenylmethyl]-imidazoles on MCF-7 and Hela cell lines. Res Pharm Sci. 2007:2:73-79

Khodarahmi GA, Shamshiri M, Hassanzadeh F. Synthesis and cytotoxic evaluation of some new 4(3H)-quinazolinones on HeLa cell line. Res Pharm Sci. 2012;7(2):119-125.

Hassanzadeh F, Rahmani Khajouei M, Hakimelahi GH, Jafari E, Khodarahmi GA. Synthesis of some new 2,3-disubstituted-4(3H)quinazolinone derivatives. Res Pharm Sci. 2012;7(1):23-30.

Garcia J, Sorrentino J, Diller EJ, Chapman D, Woydziak ZR. A general method for nucleophilic aromatic substitution of aryl fluorides and chlorides with dimethylamine using hydroxide-assisted decomposition of n,n-dimethylforamide. Synth Commun. 2016;46(5):475-481.

Singla P, Luxami V, Paul K. Quinazolinone-benzimidazole conjugates: Synthesis, characterization, dihydrofolate reductase inhibition, DNA and protein binding properties. J Photochem Photobiol B. 2017;168:156-164.

Sharma A, Luxami V, Paul K. Synthesis, single crystal and antitumor activities of benzimidazole-quinazoline hybrids. Bioorg Med Chem Lett. 2013;23(11):3288-3294.


Refbacks

  • There are currently no refbacks.


Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.